Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
-
The
TD Cowen 44th Annual Healthcare Conference inBoston, MA -
Panel Discussion: Orphan Epilepsies -
March 6 at10:30 a.m. E.T.
-
Panel Discussion: Orphan Epilepsies -
-
Leerink Partners 2024Global Biopharma Conference inMiami, FL -
Presentation -
March 11 at4:00 p.m. E.T.
-
Presentation -
Links to the events can be accessed on the Investors and Media page of Marinus’ website at ir.marinuspharma.com/events-and-presentations. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 90 days.
About
Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company first introduced FDA-approved prescription medication ZTALMY® (ganaxolone) oral suspension CV in the
View source version on businesswire.com: https://www.businesswire.com/news/home/20240221704060/en/
Investors
Senior Director, Investor Relations
jdenike@marinuspharma.com
Media
Director,
mcameron@marinuspharma.com
Source: